Age Ayurveda Nighantu Ayurvedic practitioner? List or verify your practice

Bhringraj

Eclipta prostrata

Bhringraj (Eclipta prostrata) is a plant drug, also called Kesarajah, Markavah and Bhrimgaraja. Listed in the Ayurvedic Pharmacopoeia of India (API) Part I as a hepatoprotective herb (monograph name: Bhringaraja).

Key facts
Botanical nameEclipta prostrata
FamilyAsteraceae · other entries in this family
OrderAsterales
Pharmacopoeia statusListed in the Ayurvedic Pharmacopoeia of India (API) Part I as a hepatoprotective herb (monograph name: Bhringaraja). Recognized in Ayurveda, Unani (as Bhangraa), and Siddha (as Karissalaankanni) traditional medicine systems. No standalone WHO monograph identified, but referenced in WHO traditional medicine databases. Important Ayurvedic formulations include Bhringaraja Taila, Nilibhringadi Taila, and Bhringarajasava.
Taxon identifiersGBIF 5384950 · Wikidata Q857092 · NCBI Taxonomy 53719
Names in other languages
Sanskritकेशराजः (keśarājaḥ), मार्कवः (mārkavaḥ)
Hindiभृंगराज (bhṛṃgarāja), भांगरा (bhāṃgarā), भृङ्गराज (bhṛṅgarāja)
Tamilகரிசலாங்கண்ணி

Sources: DDSA: University of Madras Tamil Lexicon, Karicalāṅkaṇṇi (கரிசலாங்கண்ணி), glossed கையாந்தகரை (Vaittiya Malai Akarāti); CRC World Dictionary of Plant Names (via wisdomlib) identifies Karisalankanni with Eclipta alba and Eclipta prostrata.; Monier-Williams (via wisdomlib): 'Keśarāja — m. Eclipta prostrata', cited to the lexicographers (Amarasiṃha, Halāyudha, Hemacandra). Note the same entry also lists Wedelia calendulacea, so it is not exclusive.; Monier-Williams (via wisdomlib): 'Mārkava — m. Eclipta Prostrata', cited to Amarakośa 2.4.5.17 and Hemacandra's Abhidhānacintāmaṇi 1187; also the 15th-century Yogasārasaṅgraha, where Mārkava is given as another name for Bhṛṅgarāja.; wisdomlib Ayurveda glossary entry for Bhṛṅgarāja: 'a Sanskrit word referring to false daisy… The official botanical name is Eclipta alba (synonym: Eclipta prostrata)', used throughout the Caraka-saṃhitā and Suśruta-saṃhitā; the same entry records the Hindi forms of the name.; wisdomlib Ayurveda glossary for Bhṛṅgarāja: 'in the Hindi language it is known as Bhāṅgrā or Bhāṅgarā'.; wisdomlib Ayurveda glossary, Bhṛṅgarāja (भृङ्गराज) = Eclipta alba / Eclipta prostrata, Caraka-saṃhitā and Suśruta-saṃhitā.. How we source.

The evidence at a glance

12papers on this site for this drug, published 1992 to 2025, every one with a DOI.

  • 5Other clinical studies and reviews
  • 7Laboratory and animal studies

A count is not a conclusion and a tier is a study design, not a verdict. Everything listed here is laboratory or animal work, which does not show an effect in people. Each paper is listed with what it measured on the page below. See the research index for how papers are tiered.

Names and identification

LanguageName
EnglishBhringraj

How does it work?

  • Hair growth: Wedelolactone activates Wnt/beta-catenin signaling pathway, increases dermal papilla cell proliferation, and binds VEGF receptor.
  • Hair growth: Inhibits 5-alpha-reductase activity (similar to finasteride); inhibits TGF-beta1 expression, promoting hair matrix cell proliferation.
  • Hair growth: Promotes anagen phase induction and sustenance through regulation of FGF-7 (upregulation) and FGF-5 (downregulation).
  • Hepatoprotection: Wedelolactone and demethylwedelolactone display hepatocyto-protective action, enabling liver cell regeneration and ameliorating hepatic injury from oxidative stress.
  • Hepatoprotection: Reduces fat deposition, mononuclear infiltration, and necrotic foci while stimulating hepatocyte regeneration.
  • Anti-inflammatory: Flavonoid constituents (luteolin, apigenin) provide antioxidant and anti-inflammatory effects on scalp tissue.
  • Antihypertensive: Increases urine volume and modulates lipid metabolism markers.

What do recent studies show?

Only studies that could be traced to a published paper are listed here. An absence here means we could not identify the source, not that no work exists.

Recent safety updates

  • Generally considered safe for most healthy adults at moderate doses; low risk of serious side effects when used appropriately.
  • Biphasic hepatic effect demonstrated: small-to-moderate doses are hepatoprotective, but large doses are hepatotoxic in animal studies.
  • Drug interaction: Eclipta significantly increases 11-beta-HSD enzyme activity, increasing plasma prednisolone concentration when coadministered with glucocorticoids.
  • Drug interaction: Reduces multidrug resistance to chemotherapy agents in human cancer cell lines via effects on P-glycoprotein systems.
  • Avoid during pregnancy and lactation due to insufficient safety data and potential liver toxicity at high doses.
  • A case report of fixed drug eruption was documented after an Ayurvedic supplement containing Eclipta alba and Withania somnifera.
  • No well-controlled human safety trials; most toxicity data derived from animal models.

Dosage forms and preparation

Dosage Forms: Churna (powder), Taila (oil), Swarasa (fresh juice), Tablet, Capsule, Kashayam (decoction), Keshya Taila (hair oil), Bhringrajasava (fermented)

Standard Dosage: 3-5g powder twice daily; 10-20ml fresh juice; 500mg extract capsule twice daily; Taila for external scalp application liberally

Optimal Timing: Morning on empty stomach for liver health; Taila application 30 minutes before hair wash; juice early morning for general rejuvenation

Storage: Powder and tablets in airtight containers away from light. Oil preparations in amber glass bottles. Fresh juice must be refrigerated and used within 72 hours.

Marker Compounds: Wedelolactone, Demethylwedelolactone, Ecliptasaponin A-D, Eclalbatin, Luteolin, Apigenin, Beta-sitosterol, Stigmasterol, Coumestan

Synergistic Combinations

  • With Amla for hair growth and Keshya Taila formulations
  • With Bhumyamalaki for hepatoprotective synergy
  • With Kutki, traditionally combined for liver support
  • With Brahmi for hair oil and cognitive benefits
  • With coconut oil or sesame oil as base for scalp application

Published research

Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.

Laboratory and animal studies7

  1. Tao X, Zhao M, Gao K and others. 2025. Wedelolactone Ameliorates Ischemic Stroke by Inhibiting Oxidative Damage and Ferroptosis via HIF-1α/SLC7A11/GPX4 SignalingDrug design, development and therapy. PMID 40810078 · doi:10.2147/DDDT.S528831
  2. Wang W, Wang H, Luo Y and others. 2024. Discovery of petroleum ether extract of eclipta targeting p53/Fas pathway for the treatment of chemotherapy-induced alopecia: Network pharmacology and experimental validationJournal of ethnopharmacology. PMID 38844249 · doi:10.1016/j.jep.2024.118405
  3. Li W, Yin X, Fu H and others. 2024. Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1/Nrf2/HO-1 axisPhytomedicine : international journal of phytotherapy and phytopharmacology. PMID 38507850 · doi:10.1016/j.phymed.2024.155401
  4. Yang J, Kim JS, Kwon YS and others. 2023. Antioxidant and Antiproliferative Activities of Eclipta prostrata (L.) L. Extract and Isolated CompoundsMolecules (Basel, Switzerland). PMID 37959773 · doi:10.3390/molecules28217354
  5. Zou YX, Mu ZQ, Wang J and others. 2022. Wedelolactone, a Component from Eclipta prostrata (L.) L., Inhibits the Proliferation and Migration of Head and Neck Squamous Cancer Cells through the AhR PathwayCurrent pharmaceutical biotechnology. PMID 35255785 · doi:10.2174/1389201023666220307110554
  6. Yu SJ, Yu JH, Yu ZP and others. 2020. Bioactive terpenoid constituents from Eclipta prostrataPhytochemistry. PMID 31726325 · doi:10.1016/j.phytochem.2019.112192
  7. Liu QM, Zhao HY, Zhong XK and others. 2012. Eclipta prostrata L. phytochemicals: isolation, structure elucidation, and their antitumor activityFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association. PMID 22902823 · doi:10.1016/j.fct.2012.08.007

Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.

Available from Age Ayurveda

This encyclopedia is published by Age Ayurveda. The products below are ours, and are listed here because they contain or use what this page describes.

Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.

Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.